The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Open accessAbstract
Background: Biomarkers may help us to unravel differences in the underlying pathophysiology between heart failure ( HF ) patients with a reduced ejection fraction ( HF r EF ) and a preserved ejection fraction ( HF p EF ). Therefore, we compared biomarker profiles to characterize pathophysiological differences between patients with HF r EF and HF p EF . Methods and Results: We retrospectively analyzed 33 biomarkers from different pathophysiological domains (inflammation, oxidative stress, remodeling, cardiac stretch, angiogenesis, arteriosclerosis, and renal function) in 460 HF patients (21% HF p EF , left ventricular ejection fraction ≥45%) measured at discharge after hospitalization for acute HF . The association between these markers and the occurrence of all‐cause mortality and/or HF ‐related rehospitalizations at 18 months was compared between patients with HF r EF and HF p EF . Patients were 70.6±11.4 years old and 37.4% were female. Patients with HF p EF were older, more often female, and had a higher systolic blood pressure. Levels of high‐sensitive C‐reactive protein were significantly higher in HF p EF , while levels of pro‐atrial‐type natriuretic peptide and N‐terminal pro‐brain natriuretic peptide were higher in HF r EF . Linear regression followed by network analyses revealed prominent inflammation and angiogenesis‐associated interactions in HF p EF and mainly cardiac stretch–associated interactions in HF r EF . The angiogenesis‐specific marker, neuropilin and the remodeling‐specific marker, osteopontin were predictive for all‐cause mortality and/or HF ‐related rehospitalizations at 18 months in HF p EF , but not in HF r EF ( P for interaction <0.05). Conclusions: In HF p EF , inflammation and angiogenesis‐mediated interactions are predominantly observed, while stretch‐mediated interactions are found in HF r EF . The remodeling marker osteopontin and the angiogenesis marker neuropilin predicted outcome in HF p EF , but not in HF r EF .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 18×
“This confirms earlier studies with regard to HFpEF and endorses the earlier proposed theory by Paulus et al.(24) Secondly, this study propagates a novel method for utilizing network analysis to analyze a wide array of biomarkers in discerning the underlying pathophysiology of disease entities in HF.”
BackgroundResultInfluentialSpironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Gao, X., Starmer, J., & Martin, E. R. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20310 · Cited by 849 · cited 2×
“This method is often used in -omics based studies, where there is a natural correlation between markers because of the fact that these often belong to similar pathophysiological processes.(14) Indeed, also for the 33 biomarkers employed in this study, biomarkers are clearly interrelated, belonging to several similar p…”
MethodNeuropilin 1: function and therapeutic potential in cancer
Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1500-0 · Cited by 233 · cited 1×
“Neuropilin is identified as a coreceptor of vascular endothelial growth factor receptor 2 (VEGFR-2).(32) In a murine model of cardiac pressure overload, animals that were heterozygous for neuropilin showed higher mortality rates.”
Background
Cited by
Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Murphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Evaluation and management of heart failure with preserved ejection fraction
Borlaug, B. A. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0363-2 · Cited by 675
Wijeysundera, D. N., Pearse, R. M., Shulman, M. A., Abbott, T. E. F., Torres, E., Ambosta, A., Croal, B. L., Granton, J. T., Thorpe, K. E., Grocott, M. P. W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31131-0 · Cited by 501
Metadata
- Authors
- Tromp, J., Khan, M. A. F., Klip, I. T., Meyer, S., de Boer, R. A., Jaarsma, T., Hillege, H., van Veldhuisen, D. J., van der Meer, P., & Voors, A. A.
- Venue
- Journal of the American Heart Association
- Published
- 2017-04-05
- Volume
- 6
- Issue
- 4
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2600611552
- Cited by
- 250
- References
- 4
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.